KR19990073578A - Magatan - Google Patents

Magatan Download PDF

Info

Publication number
KR19990073578A
KR19990073578A KR19990030477A KR19990030477A KR19990073578A KR 19990073578 A KR19990073578 A KR 19990073578A KR 19990030477 A KR19990030477 A KR 19990030477A KR 19990030477 A KR19990030477 A KR 19990030477A KR 19990073578 A KR19990073578 A KR 19990073578A
Authority
KR
South Korea
Prior art keywords
powder
smoking
ginseng
aloe
licorice
Prior art date
Application number
KR19990030477A
Other languages
Korean (ko)
Inventor
안종석
Original Assignee
안종석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 안종석 filed Critical 안종석
Priority to KR19990030477A priority Critical patent/KR19990073578A/en
Publication of KR19990073578A publication Critical patent/KR19990073578A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/17Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 금연제 및 그 금연제 제조방법에 관한 것으로서, 더욱 상세하게는 여러 종류의 한방재료를 혼합구성하여 제조되는 금연제를 흡연자에게 제공하여 흡연중에 구토 및 현기증, 두통 등의 흡연에 대한 거부반응을 유발시키면서, 흡연에 의해 발생하는 니코틴 및 타르 등의 독성과, 가래, 기침 등을 제거함으로서, 효과적으로 금연할 수 있도록 하기 위한 것이다.The present invention relates to a non-smoking agent and a method for manufacturing the non-smoking agent, and more particularly, to provide a smoker with a non-smoking agent prepared by mixing a variety of herbal ingredients to refuse smoking, such as vomiting, dizziness, headache during smoking While inducing a reaction, by removing the toxicity, such as nicotine and tar generated by smoking, sputum, cough, etc., to effectively quit smoking.

본 발명에 의한 금연제는 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 3∼5%, 오가피 분말 0.8∼1.2%, 정향 분말 1.3∼1.5%, 고본 분말 0.6∼1.0%, 백하수오 분말 1.2∼1.9%, 알로에 분말 25∼33%, 감초 분말 20∼24%, 산두근 분말 17∼22%, 전호 분말 3∼4.3%, 진피 분말 10∼13%, 인삼 분말 1.0∼1.5%, 오배자 분말 10∼1.5%가 혼합구성되어 흡연시 구토 및 현기증, 두통 등의 흡연에 대한 거부반응을 유발시키면서 흡연에 의한 니코틴 및 타르 등의 독성과 가래 및 기침이 제거되면서 금연할 수 있도록 된 것을 특징으로 한다.The anti-smoking agent according to the present invention is 0.1 to 0.5% of larvae powder, 0.2 to 0.5% of Angelica powder, 0.5 to 1% of thick gourd powder, 3 to 5% of narcissus powder, 0.8 to 1.2% of Ogapi powder, 1.3 to 1.5% of clove powder Powder 0.6-1.0%, white sewage powder 1.2-1.9%, aloe powder 25-33%, licorice powder 20-24%, wild bovine powder 17-22%, whole rice powder 3-4.3%, dermis powder 10-13%, Ginseng powder 1.0-1.5%, gall bladder powder 10-1.5% are mixed to cause the rejection of smoking, such as vomiting, dizziness and headache, while removing the toxicity and sputum and cough caused by smoking such as nicotine and tar It is characterized by being able to quit smoking.

또한, 본 발명의 금연제 제조방법은, 두충, 당귀, 후박, 나복자, 오가피, 정향, 고본, 백하수오, 알로에, 감초, 산두근, 전호, 진피, 인삼, 오배자를 건조시키는 건조단계와 상기 건조단계에서 건조된 각각의 한방재료를 분말상태로 분쇄하는 분쇄단계와 상기 분쇄단계에서 분쇄된 각각의 분말상태의 한약재를 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 3∼5%, 오가피 분말 0.8∼1.2%, 정향 분말 1.3∼1.5%, 고분 분말 0.6∼1.0%, 백하수오 분말 1.2∼1.9%, 알로에 분말 25∼33%, 감초 분말 20∼24%, 산두근 분말 17∼22%, 전호 분말 3∼4.3%, 진피 분말 10∼13%, 인삼 분말 1.0∼1.5%, 오배자 분말 1.0∼1.5%의 비율로 혼합하여 분말상의 금연제를 제조하는 혼합단계와, 상기 혼합단계에서 제조된 분말상 금연제를 0.75%씩 캡슐에 삽입하거나, 또는 물엿 3%를 혼합하여 0.15g의 크기로 환약을 제조하는 알약 단계와 포도당 5%, 말토 텍스트린 20%를 혼합한 과립형태의 제조단계로 이루어 지는 것에 특징이 있다.In addition, the method for producing a non-smoking agent of the present invention, the drying step of drying the larvae, Angelica, hoobak, nabokja, Ogapi, cloves, Gobon, Baekshou, Aloe, licorice, wild boil, Jeonho, dermis, ginseng, pear Grinding step of pulverizing each herbal material dried in the step of powder and 0.1 to 0.5% of Tooth powder, 0.2-0.5% of Angelica powder, 0.5-1% of thick powder , 3 ~ 5% moth powder, 0.8 ~ 1.2% Ogapi powder, 1.3 ~ 1.5% clove powder, 0.6 ~ 1.0% mound powder, 1.2 ~ 1.9% white sewage powder, 25 ~ 33% aloe powder, 20 ~ 24% licorice powder Mixing step to prepare powdered non-smoking agent by mixing in the ratio of 17-22%, tricepsi powder, 3-4.3% Jeonho powder, 10-13% dermis powder, 1.0-1.5% ginseng powder, 1.0-1.5% ginseng powder And, 0.75% of the powdered non-smoking agent prepared in the mixing step is inserted into capsules, or mixed with starch 3% Combined, it is characterized by consisting of a pill step of preparing a pill to a size of 0.15g and a granule form of a mixture of 5% glucose and 20% maltodulin.

Description

금연제 및 그 금연제 제조방법{Magatan}Smoking cessation agent and manufacturing method thereof [Magatan}

본 발명은 금연제 및 그 금연제 제조방법에 관한 것으로서, 더욱 상세하게는 여러 종류의 한방재료를 혼합구성하여 제조되는 금연제를 흡연자에게 제공하여 흡연중에 구토 및 현기증, 두통 등의 흡연에 대한 거부반응을 유발시키면서, 흡연에 의한 발생하는 니코틴 및 타르 등의 독성과, 가래, 기침 등을 제거함으로서, 효과적으로 금연할 수 있도록 하기 위한 것이다.The present invention relates to a non-smoking agent and a method for manufacturing the non-smoking agent, and more particularly, to provide a smoker with a non-smoking agent prepared by mixing a variety of herbal ingredients to refuse smoking, such as vomiting, dizziness, headache during smoking While inducing a reaction, by removing the toxicity, such as nicotine and tar generated by smoking, sputum, cough, etc., to effectively quit smoking.

담배 연기 속에는 약 4천여종의 화학물질이 들어있고 타르속에는 각종 독성물질과 발암물질이 약 20여종의 A급 발암물질이 포함되어 있다.There are about 4,000 kinds of chemicals in cigarette smoke, and some kinds of toxic and carcinogens contain about 20 kinds of Class A carcinogens in tar.

흡연은 치명적인 암과 관계가 있을 뿐만아니라 수면장애, 기관지염, 조기폐경, 생식능력의 저하, 청각장애, 운동기능의 저하, 뇌혈관 질환, 폐색증, 십이지장궤양, 궤양성 대장염, 위장계 질환 등의 각종 질환을 유발시키게 되어 담배중에 포함되어 있는 니코틴 및 타르에 의한 피해를 예방하기 위하여 많은 연구와 노력을 기울여 왔다.Smoking is not only associated with fatal cancer, but also includes sleep disorders, bronchitis, early menopause, decreased fertility, deafness, decreased motor function, cerebrovascular disease, obstruction, duodenal ulcer, ulcerative colitis, and gastrointestinal disorders. Many studies and efforts have been made to prevent the damage caused by nicotine and tar contained in cigarettes to cause disease.

상기와 같은 노력의 결과로 흡연을 하되, 니코틴 및 타르에 의한 피해를 최소화하기 위한 담배파이프와 패치 완전히 금연을 하기위한 식품형태의 금연보조제등이 개발되었다.As a result of the above-mentioned efforts, but smoking, tobacco pipes and patches for minimizing the damage caused by nicotine and tar, food-type anti-smoking supplements to completely quit smoking has been developed.

먼저, 가장 널리 사용되는 담배파이프는, 담배파이프의 내측에 인체에 유해한 성분인 니코틴 및 타르를 여과시키는 필터가 설치된 것으로, 이는 수회 수용하면 필터의 여과 능력이 떨어져 필터를 자주 교체해야 하는 번거로움이 있고, 애연가의 경우에는 담배맛과 흡연욕구를 불러 일으키는 니코틴과, 타르가 필터에 의해 여과되고 연기만 흡입하게 되므로 담배맛을 못 느껴서 담배파이프를 사용하지 않아 인체가 니코틴 및 타르에 손상받는 폐단이 있었다. 패치는 흡연거부반응은 있되 금단현상을 줄여주지 못한점이 있다.First, the most widely used tobacco pipe is a filter that filters nicotine and tar, which are harmful to the human body, is installed inside the tobacco pipe. In the case of smokers, nicotine causing cigarette taste and smoking desire, and tar is filtered by a filter and only smoke is inhaled, so the lungs are damaged by nicotine and tar because they do not use tobacco pipe because they do not feel tobacco taste. there was. The patch has a smoking rejection but has not reduced withdrawal.

그리고, 담배를 완전히 금연하게 하는 식품형태의 금연보조제는, 금연껌이나 보조식품등으로 개발되었는데, 이들은 그 동안 흡연으로 체내에 축적되어 있는 니코틴 및 타르를 제거시키지 않고, 단지 흡연시에만 구토감이나 현기증, 두통 등을 일으켜 흡연시 고통감으로 흡연을 하지 않도록 한 것으로, 이는 흡연을 중지하고 일정시간이 지나면 상기 체내에 축적되어 있는 니코틴에 의하여 흡연욕구를 불러 일으켜 또 다시 흡연을 하도록 된 것으로 금연에 대한 효과는 미흡한 단점을 지니고 있었다.In addition, smoking aids in the form of foods to completely quit smoking have been developed as smoking gum or supplements, which do not remove nicotine and tar accumulated in the body during smoking, and only vomiting or dizziness only during smoking , A pain, such as a headache caused by smoking to stop smoking, after a certain period of time to stop smoking by the nicotine accumulated in the body caused by the smoking desire to smoke again. The effect had inadequate disadvantages.

본 발명은 상기와 같은 종래의 문제점을 해결하기 위한 것으로서, 본 발명의 목적은, 한방재료로 제조된 금연제를 인체에 투여하면, 흡연에 대한 거부반응이 일어나도록 하면서, 그 동안 흡연으로 인체내에 축적되어 있는 흡연욕구를 불러 일으키는 니코틴과, 인체의 저항력을 떨어트리고 질병을 유발시키는 타르를 제거함으로서, 확실하게 금연할 수 있음은 물론이고 담배로 인하여 쇠약해진 인체를 건강하게 보전하도록 하는 금연제 및 그 금연제를 제조하는 금연제 제조방법을 제공하기 위한 것이다.The present invention is to solve the conventional problems as described above, the object of the present invention, when administering a non-smoking agent made of herbal materials to the human body, while causing a rejection to smoking, while smoking in the human body Nicotine, which causes accumulated smoking desire, and tar, which reduces the body's resistance and causes disease, can be reliably prevented, as well as a smoking cessation agent that keeps the body debilitated by cigarettes healthy. An object of the present invention is to provide a method for producing a non-smoking agent.

상기와 같은 목적을 달성하기 위한 본 발명에 의한 금연제는, 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 3∼5%, 오가피 분말 0.8∼1.2%, 정향 분말 1.3∼1.5%, 고분 분말 0.6∼1.0%, 백하수오 분말 1.2∼1.9%, 알로에 분말 25∼33%, 감초 분말 20∼24%, 산두근 분말 17∼22%, 전호 분말 3∼4.3%, 진피 분말 10∼13%, 인삼 분말 1.0∼1.5%, 오배자 분말 1.0∼1.5%가 혼합구성되어 흡연시 구토 및 현기증, 두통 등의 흡연에 대한 거부반응을 유발시키면서 흡연에 의한 니코틴 및 타르 등의 독성과 가래 및 기침이 제거되면서 금연할 수 있도록 된 것을 특징으로 한다.The anti-smoking agent according to the present invention for achieving the above object is 0.1 to 0.5% of larvae powder, 0.2 to 0.5% of Angelica powder, 0.5 to 1% of thick gourd powder, 3 to 5% of nacresporum powder, 0.8 to 1.2% of Ogapi powder , 1.3-1.5% of clove powder, 0.6-1.0% of tomb powder, 1.2-1.9% of white sewage powder, 25-33% of aloe powder, 20-24% of licorice powder, 17-22% of wild boar powder, 3-4.3 of Jeonho powder %, Dermis powder 10-13%, ginseng powder 1.0-1.5%, gall bladder powder 1.0-1.5%, nicotine and tar by smoking, causing rejection of smoking such as vomiting, dizziness, headache, etc. Toxic and phlegm and cough have been removed, characterized in that to be able to quit smoking.

또한, 본 발명의 금연제 제조방법은, 두충, 당귀, 후박, 나복자, 오가피, 정향, 고본, 백하수오, 알로에, 감초, 산두근, 전호, 진피, 인삼, 오배자를 건조시키는 건조단계와, 상기 건조단계에서 건조된 각각의 한약재를 분말상태로 분쇄하는 분쇄단계와, 상기 분쇄단계에서 분쇄된 각각의 분말상태의 한방재료를 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 3∼5%, 오가피 분말 0.8∼1.2%, 정향 분말 1.3∼1.5%, 고본 분말 0.6∼1.0%, 백하수오 분말 1.2∼1.9%, 알로에 분말 25∼33%, 감초 분말 20∼24%, 산두근 분말 17∼22%, 전호 분말 3∼4.3%, 진피 분말 10∼13%, 인삼 분말 1.0∼15% 오배자 분말 1.0∼1.5%의 비율로 혼합하여 분말상의 금연제를 제조하는 혼합단계와, 상기 혼합단계에서 제조된 분말상 금연제를 0.75g 씩 캡슐에 삽입하거나, 또는 물엿 3%를 혼합하여 0.15%의 크기로 환약을 제조하는 알약 단계와 포도당 5% 알토텍스트린 20%를 혼합한 과립형태의 제조단계로 이루어지는 것에 특징이 있다.In addition, the method for producing a smoking cessation agent of the present invention, the drying step of drying the larvae, Angelica, hoobak, nabokja, agapi, cloves, gobon, Baekshou, aloe, licorice, wild boil, Jeonho, dermis, ginseng, pear The pulverizing step of pulverizing the respective herbal medicines dried in the drying step in powder form, and 0.1 to 0.5% of Tobacco powder, 0.2 to 0.5% of Angelica powder, 0.5 to 0.5 thick powder 1%, 3 ~ 5% nachos powder, 0.8 ~ 1.2% Ogapi powder, 1.3 ~ 1.5% cloves powder, 0.6 ~ 1.0% hard bone powder, 1.2 ~ 1.9% white sewage powder, 25 ~ 33% aloe powder, 20 ~ 20 licorice powder Mixing to produce powdery non-smoking agent by mixing at the ratio of 24%, wild bovine powder 17-22%, Jehoho powder 3-4.3%, dermis powder 10-13%, ginseng powder 1.0-15% gall bladder powder 1.0-1.5% Step and the powdered non-smoking agent prepared in the mixing step 0.75g each by inserting a capsule, or syrup 3% The combined is characterized in comprising a step for preparing a mixture of pellets to prepare the pills to a size of 0.15% glucose and 5% to 20% lean Alto text granular form.

도1은 본 발명에 따른 금연제 제조방법을 나타내는 공정도이다.1 is a process chart showing a method for manufacturing a smoking cessation agent according to the present invention.

이하, 본 발명에 따른 금연제에 대하여 상세하게 설명하면 다음과 같다.Hereinafter, described in detail with respect to the non-smoking agent according to the present invention.

즉, 본 발명의 금연제는, 두충, 당귀, 후박, 신선한 나복자, 오가피, 정향, 고본, 백하수오, 알로에, 감초, 산두근, 전호, 진피, 인삼, 오배자를 채취한 뒤에 이를 청결하게 세척을 하고 이를 건조시킨다.(건조단계)In other words, the smoking cessation agent of the present invention, larvae, Angelica, hoobak, fresh nabokbokki, Ogapi, cloves, gobon, Baekshou, aloe, licorice, wild boil, Jeonho, dermis, ginseng, gall bladder after cleaning it cleanly And dry it (drying step).

상기와 같이 건조된 각각의 한방재료를 분쇄하여 분말상태의 금연제 재료를 얻는다. (분쇄단계) 그뒤에 상기 분쇄단계에서 분쇄된 각각의 분말상태의 금연제 재료를 혼합하는 데 각각의 혼합비율과 각각의 효능은 표 1과 같다.Each herbal material dried as described above is pulverized to obtain a powder-free smoking agent material. (Pulverization Step) Then, the mixing ratios and the effects of the respective mixing ratios of the powdered non-smoking agent materials pulverized in the pulverization step are shown in Table 1.

상기 혼합단계에서 제조된 분말상 금연제는 그 다음 단계로 금연제의 복용이 용이하도록 알약형태로 제조하는데, 첫 번째 방법으로는 상기 분말상의 금연제를 0.75g씩 캡슐에 담아서 알약을 제조하는 방법과, 두 번째 방법으로 상기 여러종류의 한방재료가 혼합된 분말상의 금연제에 물엿을 혼합하여 0.15g의 크기로 환약(丸藥)을 제조하는 방법과 포도당과 말토텍스트린을 혼합한 과립형태로 제조한다. 상기 포도당과 말토렉스트린의 함량은 포도당이 5% 말토텍스트린 20%가 바람직하다.The powdered smoking cessation agent prepared in the mixing step is prepared in the form of a pill to facilitate the taking of the smoking cessation agent in the next step. The first method is to prepare a pill by capturing 0.75g of the powdered smoking cessation agent in capsules; In the second method, the syrup is mixed with a powdered non-smoking agent mixed with the various kinds of herbal ingredients to prepare a pill in a size of 0.15 g, and a granule form of glucose and maltotextin is mixed. . The content of glucose and maltorextrin is preferably 5% maltotextrin 5% glucose.

상기 물엿의 함량은 3%가 바람직하며, 하절기에는 맥아 또는 전분, 밀가루 등을 상기 분말상의 금연제와 혼합할 수 있다.The content of the starch syrup is preferably 3%, and in summer, malt or starch, wheat flour, etc. may be mixed with the powdery non-smoking agent.

상기와 같은 제조방법을 통해 제조된 금연제는, 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 3∼5%, 오가피 분말 0.8∼1.2%, 정향 분말 1.3∼1.5%, 고본 분말 0.6∼1.0%, 백하수오 분말 1.2∼1.9%, 알로에 분말 25∼33%, 감초 분말 20∼24%, 산두근 분말 17∼22%, 전호 분말 3∼4.3%, 진피 분말 10∼13%, 인삼 분말 1.0∼1.5%, 오배자 분말 1.0∼15%가 혼합구성되어 흡연시 니코틴 및 타르 등의 독성과 가래 및 기침이 제거되면서 구토 및 현기증, 두통이 유발되어 금연할 수 있도록 된 것이다.The non-smoking agent prepared through the manufacturing method as described above, 0.1 to 0.5% of larvae powder, 0.2 to 0.5% of Angelica powder, 0.5 to 1% of thick gourd powder, 3 to 5% of nachoja powder, 0.8 to 1.2% of Ogapi powder, clove powder 1.3-1.5%, solid powder 0.6-1.0%, white sewage powder 1.2-1.9%, aloe powder 25-33%, licorice powder 20-24%, wild bovine powder 17-22%, whole rice powder 3-4.3%, dermis 10 ~ 13% of powder, 1.0 ~ 1.5% of ginseng powder, 1.0 ~ 15% of gall bladder powder are mixed, so smoking, nicotine and tar, sputum and cough are eliminated, so that vomiting, dizziness and headache can be caused. It is.

상기 금연제의 한방재료중에 두충, 당귀, 후박, 나복자, 오가피, 정향, 고본, 백하수오, 알로에, 감초, 산두근을 혼합하면, 그 동안 인체내에 축적되어 있던 니코틴과 타르 등의 독성이 제거되는 효과와, 가래 및 기침을 제거하는 효과가 있으며, 전호, 진피, 인삼, 오배자를 혼합한 경우에는 구토 및 현기증 그리고 두통을 유발시키는 특성이 있다.Among the herbal ingredients of the smoking cessation agent, tofu, donkey, hoobak, nabokjak, agap, cloves, bonbon, white haewao, aloe, licorice, and triceps are mixed to remove the toxicity of nicotine and tar accumulated in the human body. It is effective in removing sputum and cough, and when it is mixed with Jeonho, Dermis, Ginseng, and Ginseng, it causes vomiting and dizziness and headache.

따라서, 상기 두충, 당귀, 후박, 나복자, 오가피, 정향, 고본, 백하수오, 알로에, 감초, 산두근과, 전호, 진피, 인삼, 오배자를 혼합한 금연제를 복용하면 복용 초기에는 구토 및 현기증 그리고 두통의 거부반응이 일어나면서 차차로 상기와 같이 그 동안 인체내에 축적되어 있던 니코틴과 타르 등의 독성과, 가래 및 기침이 제거되어 금연할 수 있도록 된 것이다.Therefore, if you take a non-smoking agent mixed with the larvae, Angelica, hoobok, nabokbok, agar, clove, hardwood, baekshou, aloe, licorice, wild bovine, Jeonho, dermis, ginseng, galleng, nausea and dizziness at the beginning As the rejection of the headache occurs gradually, as described above, nicotine and tar, such as nicotine and tar, accumulated sputum and cough have been eliminated to quit smoking.

한편, 본 발명의 다른 실시예는, 상기 두충, 당귀, 후박, 나복자, 오가피, 정향, 고본, 백하수오, 알로에, 감초, 산두근을 분쇄 혼합하여 금연제로 사용할 수 있도록 하였다.On the other hand, another embodiment of the present invention, the larvae, Angelica, hoobak, nabokjak, scabies, cloves, gobon, white sewage, aloe, licorice, wild boiled so as to be used as a non-smoking.

다른 실시예에 의한 금연제는, 상기 일 실시예에 의한 금연제와 제조방법이 한방재료 혼합단계에서 한방재료의 혼합재료와 혼합비율만 다르고, 나머지는 모두 동일하므로 한방재료의 혼합재료와 혼합비율에 대해서만 설명한다.According to another embodiment, the smoking cessation agent and the manufacturing method of the embodiment are different from the mixing material and mixing ratio of the herbal ingredients in the mixing step of the herbal medicine, and the remainder are all the same, so the mixing material and mixing ratio of the herbal ingredients Explain only about.

상기 다른 실시예에 의한 금연제는 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 4∼6%, 오가피 분말 1.0∼1.5%, 정향분말 3.5∼3.9%, 고본 분말 0.9∼1.2%, 백하수오 분말 1∼2.2%, 알로에 분말 35∼39%, 감초 분말 25∼28%, 산두근 분말 22∼26%를 혼합구성되어 흡연시 니코틴 및 타르 등의 독성과 가래 및 기침이 제거될수 있도록 하였다.The anti-smoking agent according to the other embodiment of the present invention is 0.1 to 0.5% of larvae powder, 0.2 to 0.5% of Angelica powder, 0.5 to 1% of thick gourd powder, 4 to 6% of naperella powder, 1.0 to 1.5% of Ogapi powder, and 3.5 to 3.9% of clove powder. It is composed of 0.9 ~ 1.2% of original powder, 1-2.2% of white powder, 35-39% of aloe powder, 25-28% of licorice powder, 22-26% of triceps powder, and it contains the toxicity of nicotine and tar when smoking. Sputum and cough can be removed.

위에서 살펴본바와 같이 일실시예에 의한 금연제와, 다른 실시예에 의한 금연제의 복용은, 캡슐로 제조된 경우에는 1회 0.75g짜리 캡슐 4개를 복용하며 1일 3회씩 8일간 복용하고, 환약의 경우에는 1회 0.15g짜리 환약 20개를 복용하며 1일 3회씩 8일간 복용하고 과립형태의 경우 1회 4g씩 1일 3회 8일간 복용한다.As described above, the non-smoking agent according to one embodiment and the non-smoking agent according to another embodiment, when manufactured in capsules, take four capsules of 0.75 g once a day, three times a day for 8 days, In the case of pills, take 20 pills of 0.15g once, take 3 times a day for 8 days, and in the case of granules, take 4g once a day for 3 times for 8 days.

이렇게 금연제를 복용하면, 복용후 약 3일째 되는 날부터 구토와 현기증, 두통 등의 담배에 대한 거부반응이 일어나게 되고, 8일 후에는 니코틴 및 타르 등의 독성이 인체에서 제거되게 된다.In this way, when the non-smoking agent is taken, about 3 days after taking the reaction to the cigarette, such as vomiting, dizziness, headache, and the like, after 8 days, the toxicity of nicotine and tar is removed from the human body.

이상에서 살펴본 바와 같은 금연제는, 복용 초기에 구토 및 현기증 그리고 두통의 거부반응이 일어나서 흡연에 대한 거부감을 흡연자에게 안겨주면서, 차차로 그동안 흡연으로 인체내에 축적되어 있던 니코틴과 타르 등의 독성과, 가래 및 기침을 제거하므로, 인체 내에는 흡연욕구를 불러 일으키는 니코틴이 제거된 상태이어서 완전하게 금연에 성공할 수 있는 효과가 있다.As described above, the smoking cessation agent causes nausea, dizziness, and headache rejection in the early stages of taking, giving smokers a feeling of rejection, and the toxicity of nicotine and tar accumulated in the human body by smoking, Since it removes sputum and cough, nicotine is removed in the human body, causing smoking desire, so there is an effect that can completely quit smoking.

또한, 본 발명에 의한 금연제는 인체에 유익한 한방재료로서 제조되어서, 인체를 손상시키지 않음은 물론이고, 인체에 축적되었던 독성을 제거하면서 각각의 한방재료의 약효성분에 의해 건강한 생활을 영위할 수 있도록 하는 매우 유용한 것이다.In addition, the smoking cessation agent according to the present invention is manufactured as a beneficial herbal material for the human body, not only to harm the human body, but also to lead a healthy life by eliminating the toxicity accumulated in the human body by the active ingredient of each herbal material. It is very useful to make.

Claims (3)

두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 3∼5%, 오가피 분말 0.8∼1.2%, 정향 분말 1.8∼2.3%, 고본 분말 0.6∼1.0%, 백하수오 분말 1.2∼1.9%, 알로에 분말 25∼33%, 감초 분말 20∼24%, 산두근 분말 17∼22%, 전호 분말 2.7∼4.3%, 진피 분말 10∼13%, 인삼 분말 1.0∼1.5%, 오배자 분말 1.0∼1.5%가 혼합구성되어 흡연시 구토 및 현기증, 두통 등의 흡연에 대한 거부반응을 유발시키면서 흡연에 의한 니코틴 및 타르 등의 독성과 가래 및 기침이 제거되면서 금연할 수 있도록 된 것을 특징으로 한 금연제.Tofu powder 0.1-0.5%, Angelica powder 0.2-0.5%, Thick powder 0.5-1%, Locust powder 3-5%, Ogapi powder 0.8-1.2%, Clove powder 1.8-2.3%, Bonbon powder 0.6-1.0%, White Sewage powder 1.2-1.9%, aloe powder 25-33%, licorice powder 20-24%, wild boiled powder 17-22%, whole rice powder 2.7-4.3%, dermis powder 10-13%, ginseng powder 1.0-1.5%, Maltung powder 1.0-1.5% is mixed to cause smoking rejection, such as vomiting, dizziness, headache, smoking, nicotine and tar caused by smoking and sputum and cough are eliminated while being able to quit smoking Smoking cessation. 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 4∼6%, 오가피 분말 1.0∼1.5%, 정향 분말 3.5∼3.9%, 고본 분말 0.9∼1.2%, 백하수오 분말 1.8∼2.2%, 알로에 분말 34.2∼38%, 감초 분말 25∼30%, 산두근 분말 22∼26%를 혼합구성되어 흡연시 니코틴 및 타르 등의 독성과 가래 및 기침이 제거될수 있도록 된 것을 특징으로 하는 금연제.Tofu powder 0.1-0.5%, Angelica powder 0.2-0.5%, Thick powder 0.5-1%, Nachoja powder 4-6%, Ogapi powder 1.0-1.5%, Clove powder 3.5-3.9%, Bonbon powder 0.9-1.2%, White It is composed of 1.8 ~ 2.2% of sewage powder, 34.2 ~ 38% of aloe powder, 25-30% of licorice powder and 22 ~ 26% of wild boil powder so that the toxicity, sputum and cough of nicotine and tar can be removed when smoking. A smoking cessation agent characterized by the above-mentioned. 두충, 당귀, 후박, 나복자, 오가피, 정향, 고본, 백 하수오, 알로에, 감초, 산두근, 전호, 진피, 인삼, 오배자를 건조시키는 건조단계와,Drying step of drying tofu, Angelica, hoobak, nabokbok, Ogapi, Clove, Gobon, Baek Shou, Aloe, Licorice, Sandugung, Jeonho, Dermis, Ginseng, Ginseng, 상기 건조단계에서 건조된 각각의 한방재료를 분말상태로 분쇄하는 분쇄단계와,A grinding step of grinding each herbal material dried in the drying step into a powder state; 상기 분쇄단계에서 분쇄된 각각의 분말상태의 한약재를 두충 분말 0.1∼0.5%, 당귀 분말 0.2∼0.5%, 후박 분말 0.5∼1%, 나복자 분말 3∼5%, 오가피 분말 0.8∼1.2%, 정향 분말 1.8∼2.3%, 고본 분말 0.6∼1.0%, 백하수오 분말 1.2∼1.9%, 알로에 분말 25∼33%, 감초 분말 20∼24%, 산두근 분말 17∼22%, 전호 분말 2.7∼3.3%, 진피 분말 10∼13%, 인삼 분말 1.0∼1.5%, 오배자 분말 1.0∼1.5%의 비율로 혼합하여 분말상의 금연제를 제조하는 혼합단계와 상기 혼합단계에서 제조된 분말상 금연제를 0.75g 씩 캡슐에 삽입하거나, 또는 물엿 3%를 혼합하여 0.15g의 크기로 환약을 제조하는 알약 제조단계와 포도당 5%, 말토텍스트린 20%를 첨가하여 과립형태로 제조되는 단계로 이루어지는 것을 특징으로 하는 금연제 제조방법.The powdered herbal medicines pulverized in the pulverizing step were 0.1 to 0.5% of Tobacco powder, 0.2 to 0.5% of Angelica powder, 0.5 to 1% of Hakbak powder, 3 to 5% of Nachoja powder, 0.8 to 1.2% of Ogapi powder, and clove powder. 1.8-2.3%, solid powder 0.6-1.0%, white sewage powder 1.2-1.9%, aloe powder 25-33%, licorice powder 20-24%, wild bovine powder 17-22%, whole leaf powder 2.7-3.3%, dermis 10-13% of powder, 1.0-1.5% of ginseng powder, 1.0-1.5% of gall bladder powder, and a mixing step of preparing a powdery non-smoking agent and 0.75g of powdery non-smoking agents prepared in the mixing step, respectively. Alternatively, or 3% of syrup to prepare a pill manufacturing step of preparing a pill to the size of 0.15g and glucose 5%, malto texturine 20% by adding a step of producing a non-smoking agent, characterized in that made in the form of granules. .
KR19990030477A 1999-07-26 1999-07-26 Magatan KR19990073578A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR19990030477A KR19990073578A (en) 1999-07-26 1999-07-26 Magatan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR19990030477A KR19990073578A (en) 1999-07-26 1999-07-26 Magatan

Publications (1)

Publication Number Publication Date
KR19990073578A true KR19990073578A (en) 1999-10-05

Family

ID=41263628

Family Applications (1)

Application Number Title Priority Date Filing Date
KR19990030477A KR19990073578A (en) 1999-07-26 1999-07-26 Magatan

Country Status (1)

Country Link
KR (1) KR19990073578A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010048061A (en) * 1999-11-24 2001-06-15 노성근 Apparatus for manufacturing granule of herb medicine material
KR20010070921A (en) * 2001-06-21 2001-07-27 조대훈 The method for manufacturing and composition to help stop smoking
KR20020025103A (en) * 2002-01-15 2002-04-03 (주)한국 티엠 Smoking cessation agent and manufacturing method thereof
KR20020069032A (en) * 2001-02-22 2002-08-29 박종숙 Stop smoking
KR20030000373A (en) * 2001-06-23 2003-01-06 한성신약(주) Stop smoking
KR20030013681A (en) * 2001-08-08 2003-02-15 정의달 Stop smoking
KR20030023836A (en) * 2001-09-14 2003-03-20 최윤기 The method of making a product that helps stop smoking
KR20040022763A (en) * 2002-09-07 2004-03-18 최은규 Drug for quitting smoking made of herbs and the producing method thereof
WO2006028344A1 (en) * 2004-09-09 2006-03-16 Industry-Academic Cooperation Foundation Daegu Haany University A composition comprising the purified essential oil extract and lower alcohol soluble extract isolated from angelica gigas for the prevention and treatment of nicotine addiction and withdrawal symptoms
WO2006046814A1 (en) * 2004-10-27 2006-05-04 Sk Chemicals, Co., Ltd. Sophorae subprostratae radix extract for prevention and treatment of respiratory diseases
WO2006096032A1 (en) * 2005-03-11 2006-09-14 Sun Ho Park Antioxidant supplement composition for smokers and ex-smokers and method of producing thereof
WO2012050404A2 (en) * 2010-10-15 2012-04-19 (주) 노스모 Composition containing ginseng and having nicotine removal effect

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860006951A (en) * 1985-10-24 1986-10-06 김우식 Health cigarette
KR970014771A (en) * 1997-01-16 1997-04-28 손대현 Smoking cessation agent and manufacturing method thereof
JPH09168380A (en) * 1991-07-31 1997-06-30 Yoshioki Ikeda Every plant for tobacco
KR19990000236A (en) * 1997-06-03 1999-01-15 배오성 Smoking cessation combined use and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860006951A (en) * 1985-10-24 1986-10-06 김우식 Health cigarette
JPH09168380A (en) * 1991-07-31 1997-06-30 Yoshioki Ikeda Every plant for tobacco
KR970014771A (en) * 1997-01-16 1997-04-28 손대현 Smoking cessation agent and manufacturing method thereof
KR19990000236A (en) * 1997-06-03 1999-01-15 배오성 Smoking cessation combined use and preparation method thereof

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010048061A (en) * 1999-11-24 2001-06-15 노성근 Apparatus for manufacturing granule of herb medicine material
KR20020069032A (en) * 2001-02-22 2002-08-29 박종숙 Stop smoking
KR20010070921A (en) * 2001-06-21 2001-07-27 조대훈 The method for manufacturing and composition to help stop smoking
KR20030000373A (en) * 2001-06-23 2003-01-06 한성신약(주) Stop smoking
KR20030013681A (en) * 2001-08-08 2003-02-15 정의달 Stop smoking
KR20030023836A (en) * 2001-09-14 2003-03-20 최윤기 The method of making a product that helps stop smoking
KR20020025103A (en) * 2002-01-15 2002-04-03 (주)한국 티엠 Smoking cessation agent and manufacturing method thereof
KR20040022763A (en) * 2002-09-07 2004-03-18 최은규 Drug for quitting smoking made of herbs and the producing method thereof
WO2006028344A1 (en) * 2004-09-09 2006-03-16 Industry-Academic Cooperation Foundation Daegu Haany University A composition comprising the purified essential oil extract and lower alcohol soluble extract isolated from angelica gigas for the prevention and treatment of nicotine addiction and withdrawal symptoms
WO2006046814A1 (en) * 2004-10-27 2006-05-04 Sk Chemicals, Co., Ltd. Sophorae subprostratae radix extract for prevention and treatment of respiratory diseases
US9180153B2 (en) 2004-10-27 2015-11-10 Sk Chemicals Co., Ltd. Sophorae Radix extract for prevention and treatment of respiratory diseases
WO2006096032A1 (en) * 2005-03-11 2006-09-14 Sun Ho Park Antioxidant supplement composition for smokers and ex-smokers and method of producing thereof
WO2012050404A2 (en) * 2010-10-15 2012-04-19 (주) 노스모 Composition containing ginseng and having nicotine removal effect
WO2012050404A3 (en) * 2010-10-15 2012-07-26 (주) 노스모 Composition containing ginseng and having nicotine removal effect

Similar Documents

Publication Publication Date Title
KR19990073578A (en) Magatan
CH658594A5 (en) MEDICINAL PRODUCT WITH ANTINICOTINE EFFECT AND METHOD FOR THE PRODUCTION THEREOF.
JP4100623B2 (en) Composition of herbal extract with nicotine and dioxin detoxification
CN100411553C (en) Health caring cigarette for smoking abstinence and its producing method
KR20010001582A (en) Method for manufacturing a medicine for nonsmoking using a chinese medicine
US20020153018A1 (en) Preparation of tobacco having reduced contents of nicotine and tar
US20160278428A1 (en) Tobacco substitute
JPS6119230B2 (en)
US6776169B1 (en) Ginkgo biloba L. leaves cigarette
KR970014771A (en) Smoking cessation agent and manufacturing method thereof
CN100376179C (en) Tobacco substitute and its production method
KR20030000373A (en) Stop smoking
CN104621327B (en) One kind chews sugar and preparation method thereof for mouth
KR20020069032A (en) Stop smoking
KR20020080039A (en) A making method of carcinogen free tobacco
KR100474040B1 (en) Composition for preventing and alleviating a trouble caused by smoking
KR20160037040A (en) A cigarete for prohibiton of smoking using leaver of eucommia ulmoides oliver and method thereof
JP4776474B2 (en) Herbal medicine composition
CN1939430B (en) Dispersing tablets for clearing heat,purging fire and detoxifying
KR100276416B1 (en) Cigarette substitution smoking material
KR100370390B1 (en) Composition for inducing prohibition of smoking comprising alkaloids from Radix ipecauanhae
KR20060074963A (en) Stop smoking
KR100280076B1 (en) Smoking fuel, a paper material containing herbal medicines and extracts of squid and miso
CN107308216A (en) A kind of compound liquorice lozenge and preparation method thereof
CN1233484A (en) Series health-care food for detoxication for smoking persons

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application